Stylus Medicine launches with $85m to advance in vivo gene editing
Biotech startup Stylus Medicine has launched with $85m in funding to develop a new class of in vivo genetic medicines…
All articles by Jenna Philpott
Jenna Philpott
Jenna Philpott is a news and features reporter for Pharmaceutical Technology. Jenna holds a BSc in Biochemistry and has interests in rare diseases, gene therapies, and oncology. Contact Jenna
-
-
Pharma faces 30-day deadline under Trump’s pricing order
US President Donald Trump has signed an executive order aimed at reducing prescription drug prices by linking them to what…
-
Roche plans $700m manufacturing plant in the US
Roche is deepening its manufacturing footprint in the US with plans to invest more than $700m in a new production…
-
Trump to sign order tying US drug prices to global rates
In a renewed push to overhaul pharmaceutical pricing in the US, President Donald Trump announced he will sign an executive…
-
FDA plans to expand unannounced inspections of foreign drug plants
The US Food and Drug Administration (FDA) is moving to tighten oversight of foreign manufacturers supplying the US market by…
-
Sarepta shares fall amid FDA’s CBER appointment and weak Elevidys sales
Sarepta Therapeutics saw its stock drop by 26% on 6 May after the US Food and Drug Administration (FDA) announced…
-
Eli Lilly signs $415m deal for Alchemab’s ALS therapy
UK-based Alchemab has secured a licensing agreement worth up to $415m with Eli Lilly for ATLX-1282, its investigational antibody therapy…
-
Recursion axes drug programmes to streamline pipeline
AI business Recursion Pharmaceuticals has narrowed its drug development pipeline, ending or pausing five programmes as it seeks to reduce…
-
Pliant cuts workforce by 45% following lung trial termination
Pliant Therapeutics will cut 45% of its workforce in a sweeping restructuring effort aimed at extending its cash runway, the…
-
Entering the era of prenatal gene therapies
In February 2025, researchers at St Jude Children’s Research Hospital reported the first known in utero use of Roche’s spinal…